Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AAPL Apple	$223.85 +1.0%	$231.03	$164.08 ▼ $260.10	$3.36T	1.18	52.39 million shs	37.04 million shs
JNJ Johnson & Johnson	$163.22 +0.9%	$158.04	$140.68 ▼ $169.99	$389.72B	0.47	7.08 million shs	6.75 million shs
MSFT Microsoft	$390.58 +0.2%	$407.20	$376.91 ▼ $468.35	$2.90T	0.92	19.31 million shs	13.74 million shs
PFE Pfizer	$25.05 -0.6%	$26.12	$24.48 ▼ $31.54	$142.08B	0.61	36.82 million shs	51.26 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AAPL Apple	-0.99%	+2.92%	-10.35%	-14.47%	+30.53%
JNJ Johnson & Johnson	+0.31%	-0.84%	-1.32%	+11.03%	+3.76%
MSFT Microsoft	-1.31%	+0.55%	-3.47%	-10.99%	-7.51%
PFE Pfizer	-1.44%	-3.76%	-5.54%	-5.15%	-8.69%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AAPL Apple	4.364 of 5 stars	2.3	4.0	3.3	2.8	2.1	1.7	1.9
JNJ Johnson & Johnson	4.4329 of 5 stars	2.3	3.0	4.2	3.9	3.5	2.5	0.6
MSFT Microsoft	4.9459 of 5 stars	4.5	4.0	3.3	2.9	2.7	1.7	1.9
PFE Pfizer	4.9874 of 5 stars	3.3	3.0	4.2	4.2	3.3	3.3	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AAPL Apple	2.58	Moderate Buy	$243.65	8.85% Upside
JNJ Johnson & Johnson	2.56	Moderate Buy	$171.33	4.97% Upside
MSFT Microsoft	2.93	Moderate Buy	$510.59	30.73% Upside
PFE Pfizer	2.63	Moderate Buy	$31.92	27.43% Upside

Current Analyst Ratings Breakdown

Latest AAPL, JNJ, MSFT, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/20/2025	MSFT Microsoft	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$550.00 ➝ $595.00
3/20/2025	MSFT Microsoft	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$550.00 ➝ $550.00
3/20/2025	MSFT Microsoft	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sector Outperform	$470.00
3/18/2025	AAPL Apple	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$260.00 ➝ $275.00
3/18/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/14/2025	AAPL Apple	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$325.00 ➝ $325.00
3/13/2025	MSFT Microsoft	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$425.00 ➝ $450.00
3/12/2025	AAPL Apple	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$275.00 ➝ $252.00
3/12/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/10/2025	JNJ Johnson & Johnson	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
3/10/2025	PFE Pfizer	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 3/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AAPL Apple	$395.76B	8.50	$6.96 per share	32.16	$3.77 per share	59.38
JNJ Johnson & Johnson	$88.82B	4.43	$13.41 per share	12.17	$29.69 per share	5.50
MSFT Microsoft	$261.80B	11.09	$13.94 per share	28.01	$40.72 per share	9.59
PFE Pfizer	$63.63B	2.23	$3.93 per share	6.38	$15.81 per share	1.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AAPL Apple	$93.74B	$6.30	35.53	27.30	2.44	24.30%	160.83%	30.88%	5/1/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$6.65	24.54	14.74	2.56	18.20%	34.24%	13.63%	4/15/2025 (Estimated)
MSFT Microsoft	$88.14B	$12.42	31.45	26.57	2.21	35.43%	33.36%	18.07%	4/24/2025 (Estimated)
PFE Pfizer	$8.03B	$1.41	17.77	8.27	0.64	12.62%	19.47%	8.09%	4/29/2025 (Estimated)

Latest AAPL, JNJ, MSFT, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	MSFT Microsoft	$3.20	N/A	N/A	N/A	$68.54 billion	N/A
4/15/2025	N/A	JNJ Johnson & Johnson	$2.59	N/A	N/A	N/A	$21.65 billion	N/A
2/4/2025	Q4 2024	PFE Pfizer	$0.48	$0.63	+$0.15	$0.07	$17.26 billion	$17.76 billion
1/30/2025	Q1 2025	AAPL Apple	$2.36	$2.40	+$0.04	$2.40	$124.04 billion	N/A
1/29/2025	Q2 2025	MSFT Microsoft	$3.15	$3.23	+$0.08	$3.23	$68.86 billion	N/A
1/22/2025	Q4 2024	JNJ Johnson & Johnson	$1.99	$2.04	+$0.05	$1.41	$22.44 billion	$22.52 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AAPL Apple	$1.00	0.45%	+4.60%	15.87%	13 Years
JNJ Johnson & Johnson	$4.96	3.04%	+5.43%	74.59%	63 Years
MSFT Microsoft	$3.32	0.85%	+10.22%	26.73%	23 Years
PFE Pfizer	$1.72	6.87%	+2.50%	121.99%	16 Years

Latest AAPL, JNJ, MSFT, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/11/2025	MSFT Microsoft	quarterly	$0.83	0.87%	5/15/2025	5/15/2025	6/12/2025
1/2/2025	JNJ Johnson & Johnson	quarterly	$1.24	3.43%	2/18/2025	2/18/2025	3/4/2025
1/30/2025	AAPL Apple	quarterly	$0.25	0.42%	2/10/2025	2/10/2025	2/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AAPL Apple	1.26	0.92	0.88
JNJ Johnson & Johnson	0.43	1.11	0.86
MSFT Microsoft	0.13	1.35	1.34
PFE Pfizer	0.63	1.00	0.73

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AAPL Apple	67.73%
JNJ Johnson & Johnson	69.55%
MSFT Microsoft	71.13%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
AAPL Apple	0.06%
JNJ Johnson & Johnson	0.16%
MSFT Microsoft	0.03%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AAPL Apple	164,000	15.02 billion	15.01 billion	Optionable
JNJ Johnson & Johnson	152,700	2.41 billion	2.40 billion	Optionable
MSFT Microsoft	228,000	7.43 billion	7.43 billion	Optionable
PFE Pfizer	83,000	5.67 billion	5.66 billion	Optionable

AAPL, JNJ, MSFT, and PFE Headlines

Recent News About These Companies

Pfizer: Value Play or Past Its Prime?

March 27 at 8:04 PM | fool.com

Pfizer (PFE) Under Fire for Massive Tax Avoidance Allegations

March 27 at 6:49 PM | gurufocus.com

Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals?

March 27 at 3:30 PM | uk.finance.yahoo.com

WSJ report of probe to have limited impact on Pfizer, says Citi

March 27 at 3:30 PM | markets.businessinsider.com

Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator

March 27 at 3:30 PM | msn.com

Pfizer (NYSE:PFE) Trading Down 0.2% - What's Next?

March 27 at 12:41 PM | marketbeat.com

U.S. prosecutors look into claim Pfizer delayed vaccine news, WSJ says

March 27 at 10:28 AM | markets.businessinsider.com

Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here's What We Know.

March 27 at 10:05 AM | forbes.com

Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

March 27 at 7:49 AM | financialpost.com

Norges Bank Takes $2.33 Billion Position in Pfizer Inc. (NYSE:PFE)

March 27 at 7:31 AM | marketbeat.com

Caisse Des Depots ET Consignations Acquires Shares of 304,689 Pfizer Inc. (NYSE:PFE)

March 27 at 7:29 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Stake Raised by Delta Asset Management LLC TN

March 27 at 6:50 AM | marketbeat.com

Why Pfizer Is My Largest Healthcare Position

March 27 at 6:45 AM | fool.com

AssuredPartners Investment Advisors LLC Makes New Investment in Pfizer Inc. (NYSE:PFE)

March 27 at 6:41 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Acquired by NEOS Investment Management LLC

March 27 at 6:40 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by Amica Mutual Insurance Co.

March 27 at 6:39 AM | marketbeat.com

Elo Mutual Pension Insurance Co Trims Holdings in Pfizer Inc. (NYSE:PFE)

March 27 at 6:14 AM | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Has $239.66 Million Stock Position in Pfizer Inc. (NYSE:PFE)

March 27 at 6:05 AM | marketbeat.com

Korea Investment CORP Acquires 465,700 Shares of Pfizer Inc. (NYSE:PFE)

March 27 at 5:54 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Sold by UNIVEST FINANCIAL Corp

March 27 at 5:25 AM | marketbeat.com

Modern Wealth Management LLC Raises Position in Pfizer Inc. (NYSE:PFE)

March 27 at 4:58 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Institutions Bought 3 Stocks Heavily in Q1 2025
By Thomas Hughes | March 12, 2025
View Institutions Bought 3 Stocks Heavily in Q1 2025
Resilient Investing: 3 Stocks Built to Weather Market Volatility
By Jeffrey Neal Johnson | March 17, 2025
View Resilient Investing: 3 Stocks Built to Weather Market Volatility
Apple Is Down for the Year—Opportunity or Time to Move On?
By Thomas Hughes | March 6, 2025
View Apple Is Down for the Year—Opportunity or Time to Move On?
Microsoft’s AI Strategy Eases Analyst Concerns—Is It a Buy?
By Chris Markoch | March 18, 2025
View Microsoft’s AI Strategy Eases Analyst Concerns—Is It a Buy?
Majorana 1: Can It Cement Microsoft’s Place in Quantum Computing?
By Leo Miller | March 3, 2025
View Majorana 1: Can It Cement Microsoft’s Place in Quantum Computing?

AAPL, JNJ, MSFT, and PFE Company Descriptions

Apple NASDAQ:AAPL

$223.85 +2.32 (+1.05%)

Closing price 04:00 PM Eastern

Extended Trading

$223.40 -0.45 (-0.20%)

As of 07:59 PM Eastern

Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.

Johnson & Johnson NYSE:JNJ

$163.22 +1.50 (+0.93%)

Closing price 03:59 PM Eastern

Extended Trading

$162.93 -0.29 (-0.18%)

As of 08:00 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Microsoft NASDAQ:MSFT

$390.58 +0.61 (+0.16%)

Closing price 04:00 PM Eastern

Extended Trading

$390.01 -0.57 (-0.15%)

As of 07:59 PM Eastern

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

Pfizer NYSE:PFE

$25.05 -0.16 (-0.63%)

Closing price 03:59 PM Eastern

Extended Trading

$25.05 0.00 (0.00%)

As of 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time